An immunological biomarker to predict MTX response in early RA

Harris, 1990, Rheumatoid arthritis. Pathophysiology and implications for therapy, N Engl J Med, 322, 1277, 10.1056/NEJM199005033221805

Nell, 2004, Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology, 43, 906, 10.1093/rheumatology/keh199

Quinn, 2003, Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention, Clin Exp Rheumatol, 21, 154

Quinn, 2005, Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal—Results from a twelve-month randomized, double-blind, placebo-controlled trial, Arthritis Rheum, 52, 27, 10.1002/art.20712

Emery, 2012, Combination etanercept and methotrexate provides better disease control in very early (≤4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study, Ann Rheum Dis, 71, 989, 10.1136/annrheumdis-2011-201066

Smolen, 2010, Treating rheumatoid arthritis to target: recommendations of an international task force, Ann Rheum Dis, 69, 631, 10.1136/ard.2009.123919

Smolen, 2010, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Ann Rheum Dis, 69, 964, 10.1136/ard.2009.126532

Katchamart, 2010, Predictors for remission in Rheumatoid Arthritis patients: a systematic review, Arthritis Care Res, 62, 1128, 10.1002/acr.20188

Ponchel, 2012, CD4+ T-cell subsets in rheumatoid arthritis, Int J Clin Rheumtol, 7, 37, 10.2217/ijr.11.69

Ponchel, 2002, Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis, Blood, 100, 4550, 10.1182/blood-2002-03-0671

Ponchel, 2005, IL-7 deficiency and therapy-induced lymphopenia in Rheumatoid Arthritis, Arthritis Res Ther, 7, 80, 10.1186/ar1452

Saleem, 2010, Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?, Ann Rheum Dis, 69, 1636, 10.1136/ard.2009.117341

Lawson, 2006, Rheumatoid Arthritis is associated with a deficit in CD4+CD25high regulatory T-cell in the peripheral blood, Rheumatology, 45, 1210, 10.1093/rheumatology/kel089

Conaghan, 2003, Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis, Arthritis Rheum, 48, 64, 10.1002/art.10747

Burgoyne, 2008, Abnormal T-cell differentiation persists in rheumatoid arthritis patients in clinical remission and predicts relapse, Ann Rheum Diseases, 67, 750, 10.1136/ard.2007.073833

Baecher-Allan, 2002, Inhibition of Human CD4+CD25+high Regulatory T Cell Function, J Immunol, 169, 6210, 10.4049/jimmunol.169.11.6210

Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490

Liu, 2006, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, 203, 1701, 10.1084/jem.20060772

Hyrich, 2006, British Soc Rheumatology. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis—Results from the British Society for Rheumatology Biologics Register, Arthritis Rheum, 54, 1786, 10.1002/art.21830

Hyrich, 2006, Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 45, 1558, 10.1093/rheumatology/kel149

Burmester, 2008, Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study, Arthritis Rheum, 59, 32, 10.1002/art.23247

Emery, 2008, Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial, Lancet, 372, 375, 10.1016/S0140-6736(08)61000-4

Emery, 2010, Very early (<4 months) treatment with combination etanercept and methotrexate produces significantly better remission rates: results from the COMET study [abstract], Ann Rheum Dis, 69, S57

Pease, 1999, Does the age of onset of rheumatoid arthritis influence phenotype? a prospective study of outcome and prognostic factors, Rheumatology, 38, 228, 10.1093/rheumatology/38.3.228

Verstappen, 2005, A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up, Ann Rheum Dis, 64, 38, 10.1136/ard.2003.014928

Forslind, 2007, Sex: a major predictor of remission in early rheumatoid arthritis?, Ann Rheum Dis, 66, 46, 10.1136/ard.2006.056937

Anderson, 2000, Factors predicting response to treatment in rheumatoid arthritis—The importance of disease duration, Arthritis Rheum, 43, 22, 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9

Bukhari, 2003, Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years—Results from a large observational inception study, Arthritis Rheum, 48, 46, 10.1002/art.10727

Gregersen, 1987, The shared epitope hypothesis—an approach to understanding the molecular-genetics of susceptibility to rheumatoid- arthritis, Arthritis Rheum, 30, 1205, 10.1002/art.1780301102

Panayi, 1992, The importance of the T-Cell in initiating and maintaining the chronic synovitis of rheumatoid-arthritis, Arthritis Rheum, 35, 729, 10.1002/art.1780350702

Matthews, 1992, Rheumatoid synovial T-Cell dysfunction can be explained by low Cd45rb expression, Arthritis Rheum, 35, S224

Matthews, 1993, Subpopulations of Primed-T Helper-Cells in Rheumatoid-Arthritis, Arthritis Rheum, 36, 603, 10.1002/art.1780360505

Winchester, 1994, The molecular-basis of susceptibility to rheumatoid-arthritis, Adv Immunol, 389, 10.1016/S0065-2776(08)60456-3

Salmon, 1995, The role of lymphocytes in rheumatoid arthritis, Br Med Bull, 51, 332, 10.1093/oxfordjournals.bmb.a072964

Panayi, 1996, T cell hypothesis in rheumatoid arthritis (RA) tested by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment. 1. Suppression of disease activity and acute phase response, Immunology, 89, 379

Verburg, 2005, Outcome of intensive immunosuppression and autologous stemcell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration, Ann Rheum Dis, 64, 1397, 10.1136/ard.2004.033332